Skip to content

Enhancing Cancer Care Of Rural Dwellers

Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04758338
Acronym
ENCORE
Enrollment
814
Registered
2021-02-17
Start date
2021-10-25
Completion date
2031-12-31
Last updated
2024-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Through a multi-level remote intervention, the Vanderbilt-Ingram Cancer Center (VICC) seeks to improve comprehensive cancer care delivery to patients residing in rural communities with persistent poverty. We plan to do this by using telehealth to broaden the reach of our NCI-designated comprehensive cancer center in these communities

Detailed description

Objectives: * Evaluate the clinical effectiveness of a multi-level telehealth-based intervention for rural hospitals consisting of provider access to tumor board expertise that incorporates disease, patient and molecular tumor characteristics, together with patient access to a supportive care intervention to improve cancer care delivery. * Evaluate the facilitators and barriers to future larger-scale dissemination and implementation of the multi-level intervention, designed to enhance quality rural cancer care delivery.

Interventions

OTHERVUMC telehealth services

Participants will access the CTS link (sent to them via email), which will connect them directly to a videoconference and enable them to see and hear the facilitators and other patients in the group.

OTHERInterview

25-30 participants will be interviewed

OTHEREducational materials

Participants will be provided educational materials

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Debra Friedman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Provider and Patient: \- At least 21 years of age or older and English speaking with the ability to provide informed consent * Oncology providers within designated VHAN oncology practices * Newly diagnosed or relapsed cancer patients of aforementioned oncology providers

Design outcomes

Primary

MeasureTime frame
Measure the effectiveness of a multi-level telehealth-based interventionApproximately 3 years
Estimate the facilitators to a future large-scale multi-level interventionApproximately 3 years
Estimate the barriers to a future large-scale multi-level interventionApproximately 3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026